ArticleEuropean journal of medical research2025
Temporal and joint associations of hypertension and estimated pulse wave velocity with incident cardiovascular diseases: a population-based cohort study.
Article in European journal of medical research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Association of estimated pulse wave velocity with outcomes following drug-coated balloon therapy in elderly coronary artery disease patients.Frontiers in cardiovascular medicine · 2026Article
- Association between arterial stiffness, stress and depression among undergraduate medical students in India.Bioinformation · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
backgroundArterial stiffening and hypertension are interrelated, age-associated risk factors for cardiovascular disease (CVD). This study used estimated pulse wave velocity (ePWV), a recognized but non-standardized arterial stiffness measure, to investigate the temporal sequence of arterial stiffening and hypertension, and their mediating pathway and combined effects on CVD.
methodsData were drawn from the 2011-2018 China Health and Retirement Longitudinal Study. CVD was defined as self-reported physician-diagnosed heart disease and/or stroke. Elevated arterial stiffness was identified as ePWV ≥ the wave-specific median value, and hypertension as blood pressure ≥ 140/90 mmHg, current antihypertensive medication use, or a self-reported history. Cross-lagged panel analysis and mediation analysis, and modified Poisson regression were conducted on 6868 and 10,812 participants, respectively.
resultsThe cross-lagged path coefficient from 2011 hypertension to 2015 elevated ePWV (β = 0.19, 95% CI = 0.15-0.22) was significantly greater than that from 2011 elevated ePWV to 2015 hypertension (β = 0.15, 95% CI = 0.11-0.20; P for difference = 0.007). Mediation analysis revealed an indirect association between 2011 hypertension and 2018 CVD through 2015 elevated ePWV (proportion mediated = 26.2%). Compared to normotension and normal ePWV, CVD risk was higher in those with elevated ePWV alone (RR = 1.28, 95% CI = 1.09-1.50), hypertension alone (RR = 1.39, 95% CI = 1.16-1.67), and both conditions (RR = 1.59, 95% CI = 1.39-1.82).
conclusionsHypertension likely precedes elevated ePWV, and this temporal relationship contributes to CVD progression. Individuals with hypertension and elevated ePWV had higher risks than those with either condition alone. Managing both hypertension and arterial stiffening may effectively reduce CVD risk, and ePWV could be a promising marker of arterial stiffness, especially in resource-limited settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.